MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Treatment of dopaminergic augmented RLS with Ecopipam, A D1 specific antagonist: an exploratory placebo controlled cross-over trial

    O. Titlayo, W. Ondo (Houston, TX, USA)

    Objective: To establish initial safety and preliminary efficacy of ecopipam, a D1 specific antagonist in patients currently taking dopamine agonist and demonstrating augmentation. Background: Dopamine…
  • 2019 International Congress

    What patients need – a qualitative analysis of consultations prior to deep brain stimulation in patients with Parkinson’s disease

    R. Dano, JN. Petry-Schmelzer, J. Steffen, G. Fink, M. Barbe (Cologne, Germany)

    Objective: To evaluate the different needs of patients with Parkinson’s disease (PD) prior to deep brain stimulation (DBS). Background: DBS is a well established and…
  • 2019 International Congress

    Correlation between degree of dysarthria, motor severity and quality of life in patients with Parkinson’s disease

    M. Olchik, C. Rieder, L. Scudeiro, R. Rech, R. Millette, A. Ayres (Porto Alegre, Brazil)

    Objective: To verify the relationship between clinical findings regarding dysarthria and self-perception of PD patients. Background: Dysarthria is one of the most common non-motor symptoms…
  • 2019 International Congress

    Caregiver support and its association with advanced Parkinson’s disease and clinical outcomes

    A. Fasano, L. Bergmann, V. Fung, Y. Jalundhwala, K. Onuk, Z. Pirtosek, W. Robieson, K. Seppi, A. Takáts, P. Martinez-Martin (Totronto, ON, Canada)

    Objective: To assess characteristics of advanced Parkinson’s disease (APD) patients with ongoing device-aided treatment stratified by caregiver support. Background: Observe-PD is a multicountry, cross-sectional observational…
  • 2019 International Congress

    Repetitive transcranial magnetic stimulation does not improve the sequence effect in freezing of gait

    L. Gao, T. Mi, T. Wu, P. Chan (Beijing, China)

    Objective: To investigate the effect of repetitive transcranial magnetic stimulation (rTMS) on the sequence effect (SE) in Parkinson’s disease (PD) patients with freezing of gait…
  • 2019 International Congress

    Is sprint running exercise feasible, safe and enjoyable to subjects with mild-to-moderate Parkinson’s disease?

    E. Monteiro, L. Peyré-Tartaruga, E. da Silva, A. Zanardi, P. Jimenez-Reyes, J. Morin, A. Pagnussat (Porto Alegre, Brazil)

    Objective: To test the feasibility, safety, and acceptance of sprint running exercise in subjects with mild-to-moderate Parkinson’s disease (PD). Background: Positive effects of sprint running…
  • 2019 International Congress

    Inflammatory cytokines in Saudi Parkinson cohort

    N. Alsomali, E. Al-Ofi, M. Obaid, A. Alrafiah (Riyadh, Saudi Arabia)

    Objective: To identify inflammatory diagnostic and prognostic biomarkers for PD in serum. Background: Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's…
  • 2019 International Congress

    A review of interactive voice response systems in Parkinson’s Disease

    J. Domingues, T. Guerreiro, D. Branco, A. Rodrigues, R. Bouça-Machado, J. Ferreira (Aveiro, Portugal)

    Objective: The objective of this literature revision is to review and analyze the current research on the uses of Interactive Voice Response Systems (IVRS) in…
  • 2019 International Congress

    Opsoclonus and ataxia in the setting of synchronous primary malignancies

    H. Leal Bailey, S. Wijemanne Sarathkumara, R. Knightstep (San Antonio, TX, USA)

    Objective: To present a rare case of opsoclonus with positive anti-Ri (ANNA-2) autoantibodies, secondary to synchronous multiple primary tumors. Background: Opsoclonus refers to involuntary, conjugate, saccadic…
  • 2019 International Congress

    Wearable sensor use and monitoring effect of dopamine replacement therapy on motor parameters in a real life clinical setting

    A. Podlewska, D. van Wamelen, A. Sauerbier, V. Leta, D. Trivedi, M. Parry, K. Ray Chaudhuri (Lodnon, United Kingdom)

    Objective: To explore the usefulness of wearable sensor data to inform treatment decisions in PD. Background: Wearable sensors are becoming increasingly incorporated into clinical care…
  • « Previous Page
  • 1
  • …
  • 206
  • 207
  • 208
  • 209
  • 210
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley